1619 Advisors published four articles in the past few weeks about drug pricing and access.
Public source
Publisher name
Public post
Nine more drugmakers signed pricing agreements with the administration today. That brings it to 26 companies. Secretary Kennedy said nine out of ten drugs prescribed in…
Company
1619 Advisors
Providing solutions for your global health, public affairs, and communications needs.
- Industry
- Business Consulting and Services
- Location
- Maplewood, US
- Company size
- 1 employee
About 1619 Advisors
1619 Advisors is dedicated to helping you get the fundamentals of healthcare across the globe right. Providing strategic solutions for your global health, public affairs, advocacy and communications needs, when you need it.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Reid Strategic
Reid Strategic published a post describing the confluence of events that made #340B one of the hottest elements of healthcare issues.
Research & Knowledge
Archo Advocacy
Archo Advocacy released the 2025/2026 ELAVAY Report, which measures how patient advocacy organizations evaluate pharmaceutical and biotech companies.
Research & Knowledge
Health Advances
Health Advances published the latest edition of its Sharp Strategy Spotlight, highlighting healthcare industry trends, policies, and developments.
Research & Knowledge
Best Practices, LLC
Best Practices, LLC benchmarked research across 22 biopharma leaders found that 71% of Market Access leaders rate payer relationship management as highly effective.
Research & Knowledge
Kinaura Partners